ENTITY
iX Biopharma

iX Biopharma (IXBIO SP)

5
Analysis
Health Care • Singapore
iX Biopharma is a specialty pharmaceutical and nutraceutical company that develops and commercializes innovative therapies for pain and other health conditions, leveraging proprietary sublingual drug delivery technologies such as WaferiX and WaferlogiX. Key products in development include Wafermine (ketamine wafer) for pain and BnoX (buprenorphine). The company was founded in Singapore in 2008.
more
Exchange Announcement • 27 Jul 2026 07:21

Disclosure of Interest/ Changes in Interest of Substantial Shareholder(s)/ Unitholder(s): Disclosure of Interest by Substantial Shareholder - Oversea-Chinese Banking Corporation Limited

Exchange Announcement • 15 Jul 2026 17:57

General Announcement: Press Release - Warrant Exercises Reach 92% as Mgmt & Dirs Lead Strong Insider Participation

Exchange Announcement • 15 Jul 2026 17:51

Disclosure of Interest/ Changes in Interest of Director/ Chief Executive Officer: Disclosure of Interest/Changes in Interest of Director - Eddy Lee Yip Hang

Exchange Announcement • 15 Jul 2026 17:39

Disclosure of Interest/ Changes in Interest of Director/ Chief Executive Officer: Disclosure of Interest/Changes in Interest of Director - Albert Ho Shing Tung

Exchange Announcement • 06 Jul 2026 18:15

General Announcement: Reminder Notice of Expiry of Warrants

x